Medidata Solutions (NASDAQ:MDSO)‘s stock had its “buy” rating reissued by analysts at Dougherty & Co in a report released on Thursday, Marketbeat Ratings reports. They presently have a $89.00 target price on the stock, up from their previous target price of $79.00. Dougherty & Co’s price objective would indicate a potential upside of 14.59% from the stock’s current price.
Several other research firms also recently commented on MDSO. BidaskClub raised shares of Medidata Solutions from a “hold” rating to a “buy” rating in a report on Friday, May 4th. Zacks Investment Research downgraded shares of Medidata Solutions from a “buy” rating to a “hold” rating in a report on Thursday, April 26th. ValuEngine raised shares of Medidata Solutions from a “sell” rating to a “hold” rating in a report on Thursday, April 12th. Needham & Company LLC upped their price objective on shares of Medidata Solutions to $80.00 and gave the company a “buy” rating in a report on Friday, April 20th. Finally, TheStreet raised shares of Medidata Solutions from a “c+” rating to a “b-” rating in a report on Monday, March 12th. Four equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Medidata Solutions has a consensus rating of “Buy” and an average target price of $83.71.
NASDAQ:MDSO opened at $77.67 on Thursday. The company has a market cap of $4.67 billion, a price-to-earnings ratio of 91.38, a P/E/G ratio of 3.96 and a beta of 1.49. Medidata Solutions has a twelve month low of $77.25 and a twelve month high of $78.95. The company has a current ratio of 1.63, a quick ratio of 1.49 and a debt-to-equity ratio of 0.18.
Medidata Solutions (NASDAQ:MDSO) last released its earnings results on Thursday, April 19th. The company reported $0.40 earnings per share for the quarter, topping the consensus estimate of $0.35 by $0.05. The company had revenue of $149.20 million for the quarter, compared to the consensus estimate of $146.73 million. Medidata Solutions had a net margin of 7.96% and a return on equity of 11.36%. Medidata Solutions’s revenue was up 16.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.31 EPS. equities research analysts expect that Medidata Solutions will post 0.98 earnings per share for the current year.
In related news, EVP Michael I. Otner sold 10,395 shares of the business’s stock in a transaction on Wednesday, April 25th. The shares were sold at an average price of $70.05, for a total value of $728,169.75. Following the completion of the transaction, the executive vice president now directly owns 74,165 shares in the company, valued at approximately $5,195,258.25. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO Rouven Bergmann sold 4,000 shares of the business’s stock in a transaction on Thursday, April 19th. The shares were sold at an average price of $71.50, for a total transaction of $286,000.00. Following the completion of the transaction, the chief financial officer now owns 93,744 shares of the company’s stock, valued at $6,702,696. The disclosure for this sale can be found here. Over the last quarter, insiders sold 45,231 shares of company stock valued at $3,166,939. Company insiders own 4.70% of the company’s stock.
Several institutional investors and hedge funds have recently bought and sold shares of MDSO. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in shares of Medidata Solutions by 48.3% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,242 shares of the company’s stock valued at $205,000 after purchasing an additional 1,056 shares during the period. Meadow Creek Investment Management LLC raised its position in Medidata Solutions by 31.4% during the fourth quarter. Meadow Creek Investment Management LLC now owns 3,680 shares of the company’s stock worth $233,000 after acquiring an additional 880 shares during the period. Polen Capital Management LLC raised its position in Medidata Solutions by 77.0% during the fourth quarter. Polen Capital Management LLC now owns 4,640 shares of the company’s stock worth $294,000 after acquiring an additional 2,018 shares during the period. Joel Isaacson & Co. LLC acquired a new position in Medidata Solutions during the first quarter worth $314,000. Finally, Brown Advisory Securities LLC acquired a new position in Medidata Solutions during the fourth quarter worth $356,000.
About Medidata Solutions
Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development of new therapies. The company's platform solutions include data capture and management and trial planning and management.
Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.